ArticleOncoTargets and therapy2020

Increased SNX20 and PD-L1 Levels Can Predict the Clinical Response to PD-1 Inhibitors in Lung Adenocarcinoma.

Linwei Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.